Lemaitre Vascular (LMAT) Tops Q2 EPS by 3c

Lemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.60, $0.03 better than the analyst estimate of $0.57. Revenue for the quarter came in at $64.2 million versus the consensus estimate of $62.48 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• iMetal Resources closes $3M private placement with McFarlane Lake
• Wendy's U.S. president to resign, company to create COO role